Induction of apoptosis by cationic amphiphilic drugs amiodarone and imipramine

Drug and Chemical Toxicology

Volumn 28, Issue 1, 2005, Pages 117-133

  Piccotti, Joseph R ^a   LaGattuta, Mark S ^a   Knight, Stephanie A ^a   Gonzales, Andrea J ^a   Bleavins, Michael R ^a  

^a PFIZER INC   (United States)

Author keywords

Apoptosis; Flow cytometry; Nile red; Phospholipidosis

Indexed keywords

AMIODARONE; CASPASE 2; CASPASE 3; CELL DNA; CHOLINE; DNA FRAGMENT; FLUORESCEIN ISOTHIOCYANATE; IMIPRAMINE; LIPOCORTIN 5; PHOSPHOLIPID;

ARTICLE; CELL COUNT; CELL CULTURE; CELL CYCLE S PHASE; CELL DISRUPTION; CELL PROLIFERATION; CELL STRAIN U937; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOMETRY; CYTOTOXICITY; DNA REPLICATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPIDOSIS; LYSOSOME; MITOSIS INHIBITION;

EID: 13244263120     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.1081/DCT-39743     Document Type: Article

References (27)

1. Brown, W. J., Sullivan, T. R., Greenspan, P. (1992). Nile red staining of lysosomal phospholipid inclusions. Histochemistry 97:349-354.
2. Brunk, U. T., Dalen, H., Roberg, K., Hellquist, H. B. (1997). Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic. Biol. Med. 23(4):616-626.
3. Casartelli, A., Bonato, M., Cristofori, P., Crivellente, F., Dal Negro, G., Masotto, I., Mutinelli, C., Valko, K., Bonfante, V. (2003). A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development. Cell Biol. Toxicol. 19:161-176.
4. Dake, M. D., Madison, J. M., Montgomery, C. K., Shellito, J. E., Hinchcliffe, W. A., Winkler, M. L., Bainton, D. F. (1985). Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity. Am. J. Med. 78:506-512.
5. Degterev, A., Boyce, M., Yuan, J. (2003). A decade of caspases. Oncogene 22:8543-8567.
6. Halliwell, W. H. (1997). Cationic amphiphilic drug-induced phospholipidosis. Toxicol. Pathol. 25(1):53-60.
7. Joshi, U. M., Rao, P., Kodavanti, S., Coudert, B., Dwyer, T. M., Mehendale, H. M. (1988). Types of interaction of amphiphilic drugs with phospholipid vesicles. J. Pharmacol. Exp. Ther. 246:150-157.
8. Kacew, S. (1989). Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5′-phosphate in the rat. J. Pharmacol. Exp. Ther. 248(1):360-366.
9. Kacew, S., Bergeron, M. G. (1990). Pathologic factors in aminoglycoside-induced nephrotoxicity. Toxicol. Lett. 51:241-259.
10. Kaloyanides, G. J. (1992). Drug-phospholipid interactions: role in aminoglycoside nephrotoxicity. Ren. Fail. 14(3):351-357.
11. Kishore, B. K., Ibrahim, S., Lambricht, P., Laurent, G., Maldague, P., Tulkens, P. M. (1992). Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats. J. Pharmacol. Exp. Ther. 262(1):424-432.
12. Kubo, M., Gardner, M. F., Hostetler, K. Y. (1986). Binding of propanolol and gentamicin to small unilamellar phospholipid vesicles. Contribution of ionic and hydrophilic forces. Biochem. Pharmacol. 35:3761-3765.
13. Martin, S. J., Green, D. R. (1995). Protease activation during apoptosis: death by a thousand cuts? Cell 82:349-352.
14. Mouedden, M. E., Laurent, G., Mingeot-Leclercq, M. P., Taper, H. S., Cumps, J., Tulkens, P. M. (2000). Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides. Antimicrob. Agents Chemother. 44(3):665-675.
15. Reasor, M. J. (1989). A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs. Toxicol. Appl. Pharmacol. 97:47-56.
16. Reasor, M. J., Kacew, S. (2001). Drug-induced phospholipidosis: are there functional consequences? Exp. Biol. Med. 226(9):825-830.
17. Reasor, M. J., McCloud, C. M., DiMatteo, M., Schafer, R., Ima, A., Lemaire, I. (1996). Effects of amiodarone-induced phospholipidosis on pulmonary host defense functions in rats. Proc. Exp. Biol. Med. 211:346-352.
18. Reasor, M. J., Ogle, C. L., Walker, E. R., Kacew, S. (1988). Amiodarone-induced phospholipidosis in rat alveolar macrophages. Am. Rev. Respir. Dis. 137:510-518.
19. Samadian, T., Dehpour, A. R., Amini, S., Nouhnejad, P. (1993). Inhibition of gentamicin-induced nephrotoxicity by lithium in rats. Histol. Histopath. 8:139-147.
20. Sauers, L. J., Wierda, D., Walker, E. R., Reasor, M. J. (1986). Morphological and functional changes in mouse splenic lymphocytes following in vivo and in vitro exposure to chlorphentermine. J. Immunopharmacol. 8(4):611-631.
21. Sauers, L. J., Wierda, D., Reasor, M. J. (1988). Chlorphentermine suppresses the phosphatidylinositol pathway in concanavalin A-activated mouse splenic lymphocytes. Immunopharmacol. Immunotoxicol. 10(1):1-19.
22. Shaikh, N. A., Downar, E., Butany, J. (1987). Amiodarone-an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine. Mol. Cell. Biochem. 76:163-172.
23. Sirajudeen, K. N., Gurumoorthy, P., Devaraj, H., Devaraj, S. N. (2002). Amiodarone-induced phospholipidosis: an in vivo [14C]-acetate uptake study in rat. Drug Chem. Toxicol. 25(3):247-254.
24. Takahashi, A., Earnshaw, W. C. (1996). ICE-related proteases in apoptosis. Curr. Opin. Genet. Develop. 6:50-55.
25. White, A. E., Livanos, E. M., Tlsty, T. D. (1994). Differential disruption of genomic integrity and cell cycle regulation in normal fibroblasts by the HPV oncoproteins. Genes Dev. 8:666-677.
26. Xia, Z., Appelkvist, E. L., DePierre, J. W., Nässberger, L. (1997). Tricyclic antidepressant-induced lipidosis in human peripheral monocytes in vitro, as well as in a monocyte-derived cell line, as monitored by spectrofluorimetry and flow cytometry after staining with nile red. Biochem. Pharmacol. 53:1521-1532.
27. Zerbe, R. L. (1987). Safety of fluoxetine in the treatment of obesity. Int. J. Obes. 11:191-199.